Solventum Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Solventum Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 90% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 28% of its market value (net debt). Lower than 88% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $42 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 87% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$103Over the last 3 years, every $100 of reported profit came with $103 of operating cash.
Lower than 85% of Healthcare companies in United States.
Self-Funding Ratio
3.3×Over the last 3 years its own operating cash covered its investment spending (capex) 3.3 times.
Higher than 80% of Healthcare companies in United States.
Cash Locked Ratio
$11For every $100 of sales, $11 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $21 tied up three years earlier.
Less money tied up than 78% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +2% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+2% / +5%In 3 years sales changed by +2% while total assets changed by +5%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
−28%Debt, after subtracting cash, equals 28% of its market value (net debt).
Lower than 88% of Healthcare companies in United States.
Tangible Assets Ratio
42%Of every $100 the company owns, $42 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 87% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 90% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Solventum Corporation owes $0.66 for every $1 it owns. Net profit rose 225% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
10.7Investors pay $10.7 for every $1 of Solventum Corporation's yearly profit, lower than 80% of Healthcare companies in United States.
P/B ratio
3.10The share price is 3.10 times Solventum Corporation's book value per share, higher than 57% of Healthcare companies in United States.
Market cap
$14.9 BThe total market value of all of Solventum Corporation's shares at today's price (share price × number of shares), larger than 93% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$4.8 BWhat Solventum Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$28.19Net worth divided by the number of shares. The share price of $87.45 is 3.1 times this, which is the P/B above.
Return on equity (ROE)
34.0%Solventum Corporation earned 34.0% on its shareholders' money over the last year, higher than 95% of Healthcare companies in United States.
Owes vs Owns
0.66×Solventum Corporation owes $0.66 for every $1 it owns (moderate), higher than 70% of Healthcare companies in United States.
Dividend yield
NoneSolventum Corporation does not currently pay a dividend.
Revenue growth
+1%Revenue rose 1% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Profit growth
+225%Net profit rose 225% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Profit margin
18.7%Solventum Corporation keeps $19 of every $100 of revenue as net profit.
Cash quality
0.2×Cash from Solventum Corporation's business was 0.2× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.
Interest cover
1.8×Solventum Corporation's operating profit covered its interest costs 1.8 times in the year to Dec 2025.
Cash vs debt
Net debtSolventum Corporation had $4.2 B more debt than cash (net debt) at Dec 2025.
Questions
What is Solventum Corporation's P/E ratio?
Investors pay $10.7 for every $1 of Solventum Corporation's yearly profit, lower than 80% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Solventum Corporation: $14.9 B ÷ $4.8 B (30 Jun 2026) = 3.1.
What is Solventum Corporation's return on equity?
Solventum Corporation earned 34.0% on its shareholders' money over the last year, higher than 95% of Healthcare companies in United States.
How much does Solventum Corporation owe compared with what it owns?
Solventum Corporation owes $0.66 for every $1 it owns (moderate), higher than 70% of Healthcare companies in United States.
Does Solventum Corporation pay a dividend?
No. Solventum Corporation does not currently pay a dividend.
Is Solventum Corporation's revenue growing?
Revenue rose 1% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.